PYCR1 and lung adenocarcinoma: Moreover, Yan et al. (2019) and Gao et al. (2020) demonstrated that the knockdown of PYCR1 inhibits the activation of JAK/STAT signaling in lung adenocarcinoma and colorectal cancers, respectively.